About the Janssen Pharmaceutical Companies
At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Learn more at www.janssen.com. Follow us on www.twitter.com/janssenEMEA for our latest news.
Description: Apodemus AB is a Swedish pharmaceutical company focused on the development of antiviral treatments and diagnostic tools for viral infections.We work according to the hypothesis that “A new virus group is the common environmental factor that underlie a wide range of diseases and that these diseases can be treated by antiviral therapy”. Apodemus has recently started a phase II clinical trial in Alzheimer´s diseases where the patients is treated with antivirals. Apodemus is non-public, privately owned, small pharmaceutical company. We are focused on basic research; identifying and characterizing new viruses, development of viral diagnostic tools and antiviral treatments.
CEO: Magnus Doverskog